BioLineRx (BLRX) Approved in Israel to Commence BL-8040 Phase 1
Tweet Send to a Friend
BioLineRx (Nasdaq: BLRX) announced that it has received approval from the Israeli Ministry of Health to commence a Phase 1 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
